Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Bonaldi, A."'
Autor:
Elisa Bonaldi, Chiara Gargiuli, Loris De Cecco, Arianna Micali, Maria Grazia Rizzetti, Angela Greco, Maria Grazia Borrello, Emanuela Minna
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 11, p 5744 (2021)
BRAFV600E is the most frequent oncogenic mutation identified in papillary thyroid cancer (PTC). In PTC patients who do not respond to standard treatment, BRAF inhibitors are currently tested as alternative strategies. However, as observed for other t
Externí odkaz:
https://doaj.org/article/a2747e2904224b72a40619b1f9d07820
Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma
Autor:
Emanuela Minna, Silvia Brich, Katia Todoerti, Silvana Pilotti, Paola Collini, Elisa Bonaldi, Paola Romeo, Loris De Cecco, Matteo Dugo, Federica Perrone, Adele Busico, Andrea Vingiani, Ilaria Bersani, Andrea Anichini, Roberta Mortarini, Antonino Neri, Giancarlo Pruneri, Angela Greco, Maria Grazia Borrello
Publikováno v:
Cancers, Vol 12, Iss 1, p 112 (2020)
Thyroid carcinoma (TC) comprises several histotypes with different aggressiveness, from well (papillary carcinoma, PTC) to less differentiated forms (poorly differentiated and anaplastic thyroid carcinoma, PDTC and ATC, respectively). Previous report
Externí odkaz:
https://doaj.org/article/77b7fb429a594a6d9a275ad9624e0ad4
Autor:
Loris De Cecco, Elisa Bonaldi, Emanuela Minna, Arianna Micali, Angela Greco, Maria Grazia Rizzetti, Maria Grazia Borrello, Chiara Gargiuli
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 5744, p 5744 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 11
International Journal of Molecular Sciences
Volume 22
Issue 11
BRAFV600E is the most frequent oncogenic mutation identified in papillary thyroid cancer (PTC). In PTC patients who do not respond to standard treatment, BRAF inhibitors are currently tested as alternative strategies. However, as observed for other t